Rodman & Renshaw downgraded its rating on Exact Sciences EXAS from Market Outperform to Market Perform. At the same time, the rating agency removed its price target on the company's stock. The previous price target was $7. On Tuesday, EXAS had a bad day as its shares lost 10.7% of their value to finish the day at $7.76.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
